Peginterferon α‐2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients

200760 citationsJournal Article

Authors

Makoto Kuboki · Kawasaki Medical School

Shiro Iino · Nishikawa Hospital

Tadao Okuno · Akashi Municipal City Hospital

Masao Omata · The University of Tokyo

Kendo Kiyosawa · Shinshu University Hospital

Hiromitsu Kumada · Toranomon Hospital

Norio Hayashi ·

Abstract

In Japanese patients, peg-IFNalpha-2a plus ribavirin provided significant improvement in SVR rates compared with peg-IFNalpha-2a alone in treatment-naïve patients, and was effective as re-treatment for non-responders or relapsers to previous treatment with interferon monotherapy.

Topics & Keywords

Hepatitis C virus research Liver Disease Diagnosis and Treatment Hepatitis B Virus Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Gastroenterology and Hepatology

Volume 22, Issue 5, pp. 645-652

DOI: 10.1111/j.1440-1746.2007.04834.x

Field-Weighted Citation Impact: 3.33